Preferred Label : Invokana;
Origin ID : M000604077;
Related record
https://www.has-sante.fr/jcms/p_3218337/fr/invokana
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
Sodium-Glucose Transporter 2 Inhibitors
canagliflozin
Product containing precisely canagliflozin 300 milligram/1 each conventional release
oral tablet (clinical drug)
Product containing precisely canagliflozin 100 milligram/1 each conventional release
oral tablet (clinical drug)
adult
diabetes mellitus, type 2
drug therapy, combination
metformin
insulin
Chronic kidney disease stage 2 due to type 2 diabetes mellitus (disorder)
Chronic kidney disease stage 3 due to type 2 diabetes mellitus (disorder)
guidelines for drug use
evaluation of the transparency committee
Invokana
Canagliflozin
---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/invokana-diabete-4389.html
2018
false
false
false
false
Canada
French
drug information
Canagliflozin
Invokana
---
